Latest Articles
Monthly bleeding nasal endometriosis: a case report.
Endometriosis is a chronic gynecological disease defined as the presence of functional endometrial glands and stroma outside of the uterus. Depending on the area identified, endometriosis can be pelvic and …
Published: April 14, 2026, midnight
Jeannie C. Kelly, MD, MS, on GLP-1 discontinuation during pregnancy - Contemporary OB/GYN
Jeannie C. Kelly, MD, MS, on GLP-1 discontinuation during pregnancy Contemporary OB/GYN
Published: April 13, 2026, 11:54 p.m.
Ramu Perni, MD, MBA, on red blood cell fetal antigen prenatal tests - Contemporary OB/GYN
Ramu Perni, MD, MBA, on red blood cell fetal antigen prenatal tests Contemporary OB/GYN
Published: April 13, 2026, 11:47 p.m.
Get a $20 Amazon credit when you spend $80 on P&G products - Mashable
Get a $20 Amazon credit when you spend $80 on P&G products Mashable
Published: April 13, 2026, 10 p.m.
Ruggable Presidents' Day Sale 2025 - Mashable
Ruggable Presidents' Day Sale 2025 Mashable
Published: April 13, 2026, 10 p.m.
Lena Dunham's Chronic Illness Battle - The Pain She Hid While the World Was Busy Hating Her - privatetherapyclinics.co.uk
Lena Dunham's Chronic Illness Battle - The Pain She Hid While the World Was Busy Hating Her privatetherapyclinics.co.uk
Published: April 13, 2026, 9:40 p.m.
BioNTech Reports Strong Phase 2 Data for HER2-Targeted ADC in Recurrent Endometrial Cancer - TipRanks
BioNTech Reports Strong Phase 2 Data for HER2-Targeted ADC in Recurrent Endometrial Cancer TipRanks
Published: April 13, 2026, 12:29 p.m.
Maine braces for another tick season amid promising Lyme vaccine trials - newscentermaine.com
Maine braces for another tick season amid promising Lyme vaccine trials newscentermaine.com
Published: April 13, 2026, 12:16 p.m.
Biontech prepares FDA application after strong phase II results in endometrial cancer - medwatch.com
Biontech prepares FDA application after strong phase II results in endometrial cancer medwatch.com
Published: April 13, 2026, 12:14 p.m.
GSK ovarian and womb cancer drug shows promise in early trial - FemTech World
GSK ovarian and womb cancer drug shows promise in early trial FemTech World
Published: April 13, 2026, 11:05 a.m.
Link copied to clipboard!